What are Odyssey Therapeutics, Inc.'s total assets?

Odyssey Therapeutics, Inc. (ODTX) holds $229.1M in total assets.

How much debt does Odyssey Therapeutics, Inc. have?

Odyssey Therapeutics, Inc. carries $26.1M in total debt against -$523.7M of shareholders' equity, a debt-to-equity ratio of -0.05.

How much cash does Odyssey Therapeutics, Inc. have?

Odyssey Therapeutics, Inc. holds $35.7M in cash and equivalents.

Can Odyssey Therapeutics, Inc. cover its short-term obligations?

Its current ratio is 8.33 — current assets exceed current liabilities.

Where does Odyssey Therapeutics, Inc.'s balance sheet data come from?

Every line is extracted from Odyssey Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Odyssey Therapeutics, Inc. ODTX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$35.72M-35.0%	$41.69M—	——	$54.91M—
Short-term investments	$140.03M—	$139.67M—	——	——
Prepaid expenses and other current assets	$9.35M+1,613%	$9.3M—	——	-$618K—
Total current assets	$185.1M—	$190.66M—	——	——
Property and equipment, net	$6.56M—	$7.21M—	——	——
Operating lease right-of-use assets	$17.92M—	$18.8M—	$300K—	——
Goodwill	$14.07M—	$14.33M—	——	——
Intangible assets, net	$160K—	$262K—	——	——
Other non-current assets	$5.26M—	$3.33M—	——	——
Total assets	$229.07M—	$269.79M—	——	——
Accounts payable	$8.22M—	$7.87M—	——	——
Accrued expenses	$8.62M—	$13.39M—	——	——
Operating lease liabilities, current	$5.37M—	$5.21M—	$300K—	——
Total current liabilities	$22.21M—	$26.48M—	——	——
Operating lease liabilities, non-current	$20.75M—	$21.9M—	——	——
Operating Lease Liabilities (Total)	——	——	$300K—	——
Total liabilities	$49.21M—	$54.51M—	——	——
Common stock	$0—	$0—	——	——
Additional paid-in capital	$82.85M—	$79.62M—	——	——
Retained earnings	-$606.4M—	-$568.14M—	——	——
Accumulated other comprehensive income (loss)	-$147K—	$245K—	——	——
Redeemable noncontrolling interests	$703.56M—	$703.56M—	——	——
Total stockholders' equity	-$523.69M-25.5%	-$488.28M-27.6%	——	-$417.17M—
Total liabilities and stockholders' equity	$229.07M—	$269.79M—	——	——
Short- term Investments	$140.03M—	$139.67M—	——	——
Deferred Tax Assets and Other Non-Current Assets	$5.26M—	$3.33M—	——	——
Net Investment in Lease	$17.92M—	$18.8M—	$300K—	——
Intangible assets — net	$160K—	$262K—	——	——
Operating lease right-of-use assets	$17.92M—	$18.8M—	$300K—	——
Other non-current assets	$5.26M—	$3.33M—	——	——
Operating Lease Right-of-Use Assets in Other Assets	$17.92M—	$18.8M—	$300K—	——
Software and Technology Licenses, Net	$5.26M—	$3.33M—	——	——
Other Commercial Liabilities	$8.62M—	$13.39M—	——	——
Accrued Liabilities, Current	$8.62M—	$13.39M—	——	——
Total debt	$26.13M—	$27.11M—	$300K—	——
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$0—	$0—	——	——
Series A cumulative convertible preferred units (“preferred units”) (45,412 units outstanding at December 31, 2025 and 50,687 units outstanding at December 31, 2024	$703.56M—	$703.56M—	——	——
Contingent Consideration And Warrant Liability	$6.24M—	$6.13M—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Odyssey Therapeutics, Inc.'s total assets?: Odyssey Therapeutics, Inc. (ODTX) holds $229.1M in total assets.
How much debt does Odyssey Therapeutics, Inc. have?: Odyssey Therapeutics, Inc. carries $26.1M in total debt against -$523.7M of shareholders' equity, a debt-to-equity ratio of -0.05.
How much cash does Odyssey Therapeutics, Inc. have?: Odyssey Therapeutics, Inc. holds $35.7M in cash and equivalents.
Can Odyssey Therapeutics, Inc. cover its short-term obligations?: Its current ratio is 8.33 — current assets exceed current liabilities.
Where does Odyssey Therapeutics, Inc.'s balance sheet data come from?: Every line is extracted from Odyssey Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.